Study of URC102 to Assess the Safety and Efficacy in Gout Patients

NCT02557126 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

INDUSTRY

Sponsor class

Conditions

Gout
Hyperuricemia

Interventions

DRUG: URC102
DRUG: Placebo

Sponsor

JW Pharmaceutical